Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second-line treatment (EAGLES, Korean Cancer Study Group UN18-09).
Kim M, Kim YJ, Suh KJ, Kim SH, Kim JE, Jeong J, Hong JY, Lee J, Lee SJ, Oh SY, Kim JH, Lee GW, Ahn MS, Choi W, Choi YJ, Lee T, Oum C, Kim J, Kim YS, Ahn JH.
Kim M, et al. Among authors: suh kj.
Cancer. 2024 Oct 18. doi: 10.1002/cncr.35609. Online ahead of print.
Cancer. 2024.
PMID: 39422602